Rational Design of Natural Xanthones Against Gram‐negative Bacteria
Source abstract
Abstract
Abstract Most antibiotics are ineffective against Gram‐negative bacteria owing to the existence of the outer membrane (OM) barrier. The rational design of compounds to expand their antibacterial spectra of antibiotics solely targeting Gram‐positive pathogens remains challenging. Here, the design of skeletons from natural products to penetrate the OM are deciphered. Structure‐activity relationship analysis shows the optimization of the model of natural xanthones α‐mangostin endows the broad‐spectrum antibacterial activity. Mechanistic studies demonstrate the lead compound A20 penetrates the OM in a self‐promoted pathway through electronic and hydrophobic interactions with lipopolysaccharides and phospholipids in OM. A20 displays rapid bactericidal activity by targeting the cofactor heme in the respiratory complex. The therapeutic efficacy of A20 is demonstrated in two animal models infected with multidrug‐resistant Gram‐negative bacterial pathogens. The findings elucidate the structural property and self‐promoted transportation of a class of antibacterial compounds, to facilitate the design and discovery of antibacterial agents against increasingly prevalent Gram‐negative pathogens associated with infections.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Natural Compound Pharmacology Studies · Antimicrobial Peptides and Activities · Antibiotic Resistance in Bacteria
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
National Key Laboratory of Veterinary Public Health and Safety College of Veterinary Medicine China Agricultural University No.2 Yuanmingyuan West Road Beijing 100193 China
Funding
National Key Research and Development Program of China · National Natural Science Foundation of China · Chinese Universities Scientific Fund
References (60)
Show source-provided references
1. 10.1038/s41586-023-06873-010.1038/s41586-023-06873-0 ↗
2. 10.1016/S1473-3099(15)00424-710.1016/S1473-3099(15)00424-7 ↗
3. 10.1038/s41586-018-0344-310.1038/s41586-018-0344-3 ↗
4. 10.1038/s41579-021-00638-010.1038/s41579-021-00638-0 ↗
5. 10.1038/s41586-020-2597-x10.1038/s41586-020-2597-x ↗
6. 10.1038/s41564-024-01667-010.1038/s41564-024-01667-0 ↗
7. 10.1038/s41586-023-06799-710.1038/s41586-023-06799-7 ↗
8. 10.1039/C8NP00031J10.1039/C8NP00031J ↗
9. 10.1002/advs.20210074910.1002/advs.202100749 ↗
10. 10.1038/s41586-024-07530-w10.1038/s41586-024-07530-w ↗
11. 10.1021/acs.accounts.0c0055010.1021/acs.accounts.0c00550 ↗
12. 10.1038/s41586-023-06760-810.1038/s41586-023-06760-8 ↗
13. 10.1021/jm501552x10.1021/jm501552x ↗
14. 10.1021/jm700967e10.1021/jm700967e ↗
15. 10.1039/C8RA08409B10.1039/C8RA08409B ↗
16. 10.1038/s41467-019-12364-610.1038/s41467-019-12364-6 ↗
17. 10.1038/s41564-019-0604-510.1038/s41564-019-0604-5 ↗
18. 10.1039/D1SC04019G10.1039/D1SC04019G ↗
19. 10.1021/acs.chemrev.0c0121310.1021/acs.chemrev.0c01213 ↗
20. 10.1038/s41579-019-0294-210.1038/s41579-019-0294-2 ↗
21. 10.1128/AAC.22.6.94210.1128/AAC.22.6.942 ↗
22. 10.1007/s10156-009-0716-610.1007/s10156-009-0716-6 ↗
23. 10.34133/research.024510.34133/research.0245 ↗
24. 10.1016/j.tim.2020.09.00810.1016/j.tim.2020.09.008 ↗
25. 10.1038/s41467-018-02875-z10.1038/s41467-018-02875-z ↗
26. 10.1101/cshperspect.a02702910.1101/cshperspect.a027029 ↗
27. 10.1016/j.chembiol.2013.07.00610.1016/j.chembiol.2013.07.006 ↗
28. 10.1038/s42003-021-02074-510.1038/s42003-021-02074-5 ↗
29. 10.1038/s41467-022-29493-010.1038/s41467-022-29493-0 ↗
30. 10.1038/s41579-018-0048-610.1038/s41579-018-0048-6 ↗
31. 10.1038/s41557-023-01319-610.1038/s41557-023-01319-6 ↗
32. 10.1073/pnas.190178811610.1073/pnas.1901788116 ↗
33. 10.1016/j.tim.2021.12.00710.1016/j.tim.2021.12.007 ↗
34. 10.1038/s41579-020-00486-410.1038/s41579-020-00486-4 ↗
35. 10.1038/417463a10.1038/417463a ↗
36. 10.1038/s41596-018-0001-110.1038/s41596-018-0001-1 ↗
37. 10.1111/j.1747-0285.2010.00972.x10.1111/j.1747-0285.2010.00972.x ↗
38. 10.1021/acscentsci.0c0162110.1021/acscentsci.0c01621 ↗
39. 10.1146/annurev-nutr-062320-11262510.1146/annurev-nutr-062320-112625 ↗
40. 10.1038/s41467-020-15083-510.1038/s41467-020-15083-5 ↗
41. 10.1038/s41467-017-02712-910.1038/s41467-017-02712-9 ↗
42. 10.1038/s41586-024-07502-010.1038/s41586-024-07502-0 ↗
43. 10.1038/s41467-022-33838-010.1038/s41467-022-33838-0 ↗
44. 10.1038/s41467-019-11503-310.1038/s41467-019-11503-3 ↗
45. Clinical and Laboratory Standards Institute (CLSI). M100 Performance Standards for Antimicrobial Susceptibility Testing 32nd Ed.October 5 2022.
46. 10.1093/jac/dkg30110.1093/jac/dkg301 ↗
47. 10.1038/s41564-020-0723-z10.1038/s41564-020-0723-z ↗
48. 10.1038/nmicrobiol.2017.2810.1038/nmicrobiol.2017.28 ↗
49. 10.1128/AAC.00824-0710.1128/AAC.00824-07 ↗
50. 10.1046/j.1365-2672.2000.00971.x10.1046/j.1365-2672.2000.00971.x ↗
51. 10.1016/j.chembiol.2018.01.00510.1016/j.chembiol.2018.01.005 ↗
52. 10.1074/jbc.M115.66536410.1074/jbc.M115.665364 ↗
53. 10.1073/pnas.160032111310.1073/pnas.1600321113 ↗
54. 10.1128/AAC.02536-1310.1128/AAC.02536-13 ↗
55. 10.1016/j.bbamem.2019.05.02010.1016/j.bbamem.2019.05.020 ↗
56. 10.1016/j.colsurfb.2021.11201610.1016/j.colsurfb.2021.112016 ↗
57. 10.1038/nature1862910.1038/nature18629 ↗
58. 10.1002/jcc.2029110.1002/jcc.20291 ↗
59. 10.1371/journal.ppat.100461810.1371/journal.ppat.1004618 ↗
60. 10.1002/cac2.1218410.1002/cac2.12184 ↗